Increased atherosclerosis in diabetic dyslipidemic swine: Protection by atorvastatin involves decreased VLDL triglycerides but minimal effects on the lipoprotein profile

Joseph L. Dixon, Siming Shen, James P. Vuchetich, Elzbieta Wysocka, Grace Y. Sun, Michael Sturek

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Male Yucatan swine were allocated to four groups (n = 5-6 pigs per group): low fat (3%) fed control, high fat/2% cholesterol (CH) fed (HF), high fat/CH fed with alloxan-induced diabetes (DF) and DF pigs that were treated with atorvastatin (80 mg/day; DF+A). Pigs were fed two meals per day and daily insulin injections were used in diabetic pigs to maintain plasma glucose between 250 and 350 mg/dl. Diabetic dyslipidemic (DF) pigs exhibited greater coronary atherosclerosis and increased collagen deposition in internal mammary artery compared with normoglycemic hyperlipidemic pigs. Although total and LDL CH concentrations did not differ, triglyceride (TG) were increased in DF pigs and FPLC analysis indicated that the LDL/HDL CH ratio was significantly increased in DF compared with HF pigs. The LDL fraction of DF pigs contained larger, lipid enriched particles resembling IDL. Consumption of the high fat/CH diet caused a moderate increase in the percentage of 14:0 fatty acids in plasma lipids and this was compensated by small-moderate declines in several unsaturated fatty acids. There was a significant increase in phospholipid arachidonic acid in DF compared with HF pigs. Atorvastatin protected diabetic pigs from atherosclerosis and decreased total and VLDL TG, but exerted minimal effects on the FPLC lipoprotein and plasma fatty acid profiles and plasma concentrations of total and LDL CH, vitamin A, vitamin E, and lysophosphatidylcholine. Across all groups the plasma CH concentration was positively correlated with hepatic CH concentration. These findings suggest that atorvastatin's protection against coronary artery atherosclerosis in diabetes may involve effects on plasma VLDL TG concentration. Lack of major effects on other lipid parameters, including the LDL/HDL ratio, suggests that atorvastatin may have yet other anti-atherogenic effects, possibly directly in the vessel wall.

Original languageEnglish (US)
Pages (from-to)1618-1629
Number of pages12
JournalJournal of Lipid Research
Volume43
Issue number10
DOIs
StatePublished - Oct 1 2002
Externally publishedYes

Fingerprint

Lipoproteins
Atherosclerosis
Swine
Plasmas
Cholesterol
Fats
Medical problems
Lipids
LDL Cholesterol
Fatty Acids
Lysophosphatidylcholines
Alloxan
Nutrition
Unsaturated Fatty Acids
Arachidonic Acid
HDL Cholesterol
Atorvastatin Calcium
very low density lipoprotein triglyceride
Coronary Artery Disease
Phospholipids

Keywords

  • Arachidonic acid
  • Cholesterol
  • Coronary artery
  • Endothelium
  • HDL
  • Hypertriglyceridemia
  • LDL
  • Remnants
  • Statin
  • Triglycerides
  • Vascular smooth muscle
  • Vitamin E
  • Yucatan miniature swine

ASJC Scopus subject areas

  • Endocrinology

Cite this

Increased atherosclerosis in diabetic dyslipidemic swine : Protection by atorvastatin involves decreased VLDL triglycerides but minimal effects on the lipoprotein profile. / Dixon, Joseph L.; Shen, Siming; Vuchetich, James P.; Wysocka, Elzbieta; Sun, Grace Y.; Sturek, Michael.

In: Journal of Lipid Research, Vol. 43, No. 10, 01.10.2002, p. 1618-1629.

Research output: Contribution to journalArticle

@article{53daf36dcd1d441fb9c8f5b916e52575,
title = "Increased atherosclerosis in diabetic dyslipidemic swine: Protection by atorvastatin involves decreased VLDL triglycerides but minimal effects on the lipoprotein profile",
abstract = "Male Yucatan swine were allocated to four groups (n = 5-6 pigs per group): low fat (3{\%}) fed control, high fat/2{\%} cholesterol (CH) fed (HF), high fat/CH fed with alloxan-induced diabetes (DF) and DF pigs that were treated with atorvastatin (80 mg/day; DF+A). Pigs were fed two meals per day and daily insulin injections were used in diabetic pigs to maintain plasma glucose between 250 and 350 mg/dl. Diabetic dyslipidemic (DF) pigs exhibited greater coronary atherosclerosis and increased collagen deposition in internal mammary artery compared with normoglycemic hyperlipidemic pigs. Although total and LDL CH concentrations did not differ, triglyceride (TG) were increased in DF pigs and FPLC analysis indicated that the LDL/HDL CH ratio was significantly increased in DF compared with HF pigs. The LDL fraction of DF pigs contained larger, lipid enriched particles resembling IDL. Consumption of the high fat/CH diet caused a moderate increase in the percentage of 14:0 fatty acids in plasma lipids and this was compensated by small-moderate declines in several unsaturated fatty acids. There was a significant increase in phospholipid arachidonic acid in DF compared with HF pigs. Atorvastatin protected diabetic pigs from atherosclerosis and decreased total and VLDL TG, but exerted minimal effects on the FPLC lipoprotein and plasma fatty acid profiles and plasma concentrations of total and LDL CH, vitamin A, vitamin E, and lysophosphatidylcholine. Across all groups the plasma CH concentration was positively correlated with hepatic CH concentration. These findings suggest that atorvastatin's protection against coronary artery atherosclerosis in diabetes may involve effects on plasma VLDL TG concentration. Lack of major effects on other lipid parameters, including the LDL/HDL ratio, suggests that atorvastatin may have yet other anti-atherogenic effects, possibly directly in the vessel wall.",
keywords = "Arachidonic acid, Cholesterol, Coronary artery, Endothelium, HDL, Hypertriglyceridemia, LDL, Remnants, Statin, Triglycerides, Vascular smooth muscle, Vitamin E, Yucatan miniature swine",
author = "Dixon, {Joseph L.} and Siming Shen and Vuchetich, {James P.} and Elzbieta Wysocka and Sun, {Grace Y.} and Michael Sturek",
year = "2002",
month = "10",
day = "1",
doi = "10.1194/jlr.M200134-JLR200",
language = "English (US)",
volume = "43",
pages = "1618--1629",
journal = "Journal of Lipid Research",
issn = "0022-2275",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "10",

}

TY - JOUR

T1 - Increased atherosclerosis in diabetic dyslipidemic swine

T2 - Protection by atorvastatin involves decreased VLDL triglycerides but minimal effects on the lipoprotein profile

AU - Dixon, Joseph L.

AU - Shen, Siming

AU - Vuchetich, James P.

AU - Wysocka, Elzbieta

AU - Sun, Grace Y.

AU - Sturek, Michael

PY - 2002/10/1

Y1 - 2002/10/1

N2 - Male Yucatan swine were allocated to four groups (n = 5-6 pigs per group): low fat (3%) fed control, high fat/2% cholesterol (CH) fed (HF), high fat/CH fed with alloxan-induced diabetes (DF) and DF pigs that were treated with atorvastatin (80 mg/day; DF+A). Pigs were fed two meals per day and daily insulin injections were used in diabetic pigs to maintain plasma glucose between 250 and 350 mg/dl. Diabetic dyslipidemic (DF) pigs exhibited greater coronary atherosclerosis and increased collagen deposition in internal mammary artery compared with normoglycemic hyperlipidemic pigs. Although total and LDL CH concentrations did not differ, triglyceride (TG) were increased in DF pigs and FPLC analysis indicated that the LDL/HDL CH ratio was significantly increased in DF compared with HF pigs. The LDL fraction of DF pigs contained larger, lipid enriched particles resembling IDL. Consumption of the high fat/CH diet caused a moderate increase in the percentage of 14:0 fatty acids in plasma lipids and this was compensated by small-moderate declines in several unsaturated fatty acids. There was a significant increase in phospholipid arachidonic acid in DF compared with HF pigs. Atorvastatin protected diabetic pigs from atherosclerosis and decreased total and VLDL TG, but exerted minimal effects on the FPLC lipoprotein and plasma fatty acid profiles and plasma concentrations of total and LDL CH, vitamin A, vitamin E, and lysophosphatidylcholine. Across all groups the plasma CH concentration was positively correlated with hepatic CH concentration. These findings suggest that atorvastatin's protection against coronary artery atherosclerosis in diabetes may involve effects on plasma VLDL TG concentration. Lack of major effects on other lipid parameters, including the LDL/HDL ratio, suggests that atorvastatin may have yet other anti-atherogenic effects, possibly directly in the vessel wall.

AB - Male Yucatan swine were allocated to four groups (n = 5-6 pigs per group): low fat (3%) fed control, high fat/2% cholesterol (CH) fed (HF), high fat/CH fed with alloxan-induced diabetes (DF) and DF pigs that were treated with atorvastatin (80 mg/day; DF+A). Pigs were fed two meals per day and daily insulin injections were used in diabetic pigs to maintain plasma glucose between 250 and 350 mg/dl. Diabetic dyslipidemic (DF) pigs exhibited greater coronary atherosclerosis and increased collagen deposition in internal mammary artery compared with normoglycemic hyperlipidemic pigs. Although total and LDL CH concentrations did not differ, triglyceride (TG) were increased in DF pigs and FPLC analysis indicated that the LDL/HDL CH ratio was significantly increased in DF compared with HF pigs. The LDL fraction of DF pigs contained larger, lipid enriched particles resembling IDL. Consumption of the high fat/CH diet caused a moderate increase in the percentage of 14:0 fatty acids in plasma lipids and this was compensated by small-moderate declines in several unsaturated fatty acids. There was a significant increase in phospholipid arachidonic acid in DF compared with HF pigs. Atorvastatin protected diabetic pigs from atherosclerosis and decreased total and VLDL TG, but exerted minimal effects on the FPLC lipoprotein and plasma fatty acid profiles and plasma concentrations of total and LDL CH, vitamin A, vitamin E, and lysophosphatidylcholine. Across all groups the plasma CH concentration was positively correlated with hepatic CH concentration. These findings suggest that atorvastatin's protection against coronary artery atherosclerosis in diabetes may involve effects on plasma VLDL TG concentration. Lack of major effects on other lipid parameters, including the LDL/HDL ratio, suggests that atorvastatin may have yet other anti-atherogenic effects, possibly directly in the vessel wall.

KW - Arachidonic acid

KW - Cholesterol

KW - Coronary artery

KW - Endothelium

KW - HDL

KW - Hypertriglyceridemia

KW - LDL

KW - Remnants

KW - Statin

KW - Triglycerides

KW - Vascular smooth muscle

KW - Vitamin E

KW - Yucatan miniature swine

UR - http://www.scopus.com/inward/record.url?scp=0036795741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036795741&partnerID=8YFLogxK

U2 - 10.1194/jlr.M200134-JLR200

DO - 10.1194/jlr.M200134-JLR200

M3 - Article

C2 - 12364546

AN - SCOPUS:0036795741

VL - 43

SP - 1618

EP - 1629

JO - Journal of Lipid Research

JF - Journal of Lipid Research

SN - 0022-2275

IS - 10

ER -